MedPath

The effect of injecting of lidocaine and adrenaline in myometrium on bleeding during myomectomy

Phase 3
Recruiting
Conditions
Bleeding during myomectomy.
Registration Number
IRCT20090525001946N10
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Women of reproductive age candidate for Myomectomy
Patients with symptomatic Myoma without responding to medical treatments (laparotomy, infertility for more than 3 years with myomectomy indication)
Pain and pelvic pressure
Urination frequency and constipation
The size of the uterus is less than 18 weeks.
Not accepting hysterectomy
Myoma grade 6-2 based on ultrasound
The cause of myoma bleeding is detected

Exclusion Criteria

Adenomyosis of cervical myomas or peduncle
Coagulation problems and recurrent vascular thrombosis
Ischemic heart disease, cardiomyopathy
Women with multiple myomas
Lidocaine susceptibility c
Uncontrolled hypertension
Hyperthyroidism
Seizure
Recent use of ergot alkaloids and vasoconstrictors, triangular antidepressants and monoamine oxidase inhibitors.
Liver disease
Diabetes, asthma, COPD
Malignancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of bleeding of patients during myomectomy surgery. Timepoint: After the operation, according to the information recorded in the patient's file. Method of measurement: With the difference in hemoglobin (g / dl) before and after operation and the number of transfused blood pack cells during operation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath